GlycoMimetics Appoints Deepak Tiwari, Ph.D., as new Vice President, Technical Operations
“Dr. Tiwari brings over 25 years of diverse CMC experience. He has contributed to more than 30 regulatory submissions and 15 commercial product launches throughout his career. As we continue to move uproleselan forward, Deepak’s breadth of experience and leadership is a valuable addition to GlycoMimetics,” commented
About Uproleselan (GMI-1271)
Discovered and developed by
About
Forward-Looking Statements
This press release contains forward-looking statements regarding the planned or potential development, and the potential benefits and impact, of the Company’s drug candidates. Actual results may differ materially from those in these forward-looking statements. For a further description of the risks associated with these statements, as well as other risks facing
View source version on businesswire.com: https://www.businesswire.com/news/home/20220302005723/en/
Investor and Media:
Phone: 650-888-0902
Email: sannes@annesassociates.com
Source: